about
Prostate cancer proteomics: Current trends and future perspectives for biomarker discovery.Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics.Decreased expression of APAF-1 and increased expression of cathepsin B in invasive pituitary adenomaThe secretome of myocardial telocytes modulates the activity of cardiac stem cells.Proteomic Biomarkers Panel: New Insights in Chronic Kidney Disease.Signal transduction molecule patterns indicating potential glioblastoma therapy approaches.Circulating biomarker panels for targeted therapy in brain tumors.Epigenetics in gastric carcinogenesis: TET genes as important players.Proteomic Approaches for Biomarker Panels in Cancer.Biotechnology landscape in cancer drug discovery.Aldose reductase inhibition of a saponin-rich fraction and new furostanol saponin derivatives from Balanites aegyptiaca.Neuroendocrine Factors and Head and Neck Squamous Cell Carcinoma: An Affair to Remember.Highlights of new immunoassay-based technologiesAn exploratory study of inflammatory cytokines as prognostic biomarkers in patients with ductal pancreatic adenocarcinomaAngiogenic markers: molecular targets for personalized medicine in pituitary adenomaMultiplex assay for multiomics advances in personalized-precision medicineUpdates in immune-based multiplex assaysElevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcomeTGF-β upregulates miR-181a expression to promote breast cancer metastasisHER3: a potential marker in colon cancer
P50
Q33567004-6A0DBCF9-5749-4D33-9F2E-95108B56892FQ34067873-9F05C309-76C1-4AB7-A9BC-F3E2F07EE417Q34783764-33AD5499-A5E6-4100-8839-90CBE1B77FF6Q35692203-BD9DA5CA-00EC-4A88-B1D5-66898C3AEEE7Q37271191-033517DF-E2A3-4D8E-8667-45E332068A37Q37360227-01922B55-1F90-4235-A2F5-7EB9AAF3BDE9Q38252948-70A7E1B5-ECBF-42F1-8941-F6767928FB31Q38365055-F7BC4B9D-6162-4156-B881-0DB6F164425CQ38632577-59475A85-B626-46D2-B573-690B0FC1715BQ42358602-F97E4A3B-A99A-4C9E-9183-CF7A0687C67DQ46866331-1D7E01A1-14E7-4719-932A-B0FF41F67FC4Q55020898-84E59522-7FBD-450F-A119-307BEB2A58A1Q62476848-37103F4B-7BF2-4EF4-AF5B-34D633674898Q84432306-87F6C594-0397-4A68-B9DC-240D2E80C2CEQ88729294-A94B1F72-8130-4BCB-902A-8A9860762218Q90998062-13C0D731-2F3A-43CA-9795-26CF74CB62BFQ90998120-A1B38FCE-E160-419C-9824-F2320094E09EQ95543843-10B35BBC-A91B-4BCC-8893-9233D247B9DBQ95543846-CBAF8836-FDCA-44E5-B34C-56DDB62E9210Q95805083-9D675647-AA12-408D-9570-1D4F18628046
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Radu Albulescu
@ast
Radu Albulescu
@en
Radu Albulescu
@es
Radu Albulescu
@nl
type
label
Radu Albulescu
@ast
Radu Albulescu
@en
Radu Albulescu
@es
Radu Albulescu
@nl
prefLabel
Radu Albulescu
@ast
Radu Albulescu
@en
Radu Albulescu
@es
Radu Albulescu
@nl
P106
P108
P31
P496
0000-0002-3765-8207